Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Delcath Systems Inc (DCTH)

Delcath Systems Inc (DCTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Delcath Systems Inc 566 QUEENSBURY AVENUE QUEENSBURY NY 12804 USA

www.delcath.com P: 212-489-2100

Description:

Delcath Systems, Inc. has developed a system, the Delcath system, to isolate the liver from the general circulatory system and to administer chemotherapy and other therapeutic agents directly to the liver.

Key Statistics

Overview:

Market Capitalization, $K 142,458
Enterprise Value, $K 129,758
Shares Outstanding, K 25,439
Annual Sales, $ 2,070 K
Annual Net Income, $ -47,680 K
Last Quarter Sales, $ 540 K
Last Quarter Net Income, $ -11,140 K
EBIT, $ -38,190 K
EBITDA, $ -37,440 K
60-Month Beta 0.53
% of Insider Shareholders 17.94%
% of Institutional Shareholders 61.12%
Float, K 20,875
% Float 82.06%
Short Volume Ratio 0.39

Growth:

1-Year Return -7.63%
3-Year Return -50.95%
5-Year Return -91.32%
5-Year Revenue Growth -39.30%
5-Year Earnings Growth 99.53%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.48 on 03/26/24
Latest Earnings Date 05/27/24
Earnings Per Share ttm -2.44
EPS Growth vs. Prev Qtr 21.31%
EPS Growth vs. Prev Year 44.19%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-700 on 12/24/19

DCTH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -563.60%
Return-on-Assets % -111.13%
Profit Margin % -2,303.38%
Debt/Equity 0.00
Price/Sales 67.88
Price/Cash Flow N/A
Price/Book 6.81
Book Value/Share 0.72
Interest Coverage -32.11
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar